Oric Pharmaceuticals Inc
(ORIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,945 | -89,122 | -68,275 | -43,446 | -23,159 |
| Depreciation Amortization | -608 | -76 | 297 | 446 | 293 |
| Other Working Capital | 311 | -445 | -3,166 | -5,531 | -3,797 |
| Other Operating Activity | 3,614 | 14,500 | 11,330 | 8,037 | 3,945 |
| Operating Cash Flow | $-20,628 | $-75,143 | $-59,814 | $-40,494 | $-22,718 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,088 | -107,170 | -135,757 | -135,473 | -89,937 |
| PPE Investments | -310 | -2,078 | -1,791 | -1,390 | -723 |
| Investing Cash Flow | $12,778 | $-109,248 | $-137,548 | $-136,863 | $-90,660 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 25,624 | 432 | 431 | 16 |
| Other Financing Activity | 0 | -399 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $25,225 | $432 | $431 | $16 |
| Beginning Cash Position | 67,308 | 226,474 | 226,474 | 226,474 | 226,474 |
| End Cash Position | 59,458 | 67,308 | 29,544 | 49,548 | 113,112 |
| Net Cash Flow | $-7,850 | $-159,166 | $-196,930 | $-176,926 | $-113,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,628 | -75,143 | -59,814 | -40,494 | -22,718 |
| Capital Expenditure | -310 | -2,078 | -1,791 | -1,390 | -723 |
| Free Cash Flow | -20,938 | -77,221 | -61,605 | -41,884 | -23,441 |